Medicare Part D now covers semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management in patients who meet specific criteria, following recent policy changes, though coverage details vary by plan
DV: Validation, Resources, Data curation, Methodology, Software, Writing original draft, Investigation
If these symptoms occur, increase your fluid intake and consult your healthcare provider
In fact, Starbucks CEO Brian Niccol has pointed to the companys shift toward a protein-forward menu as a direct response to the eating behaviors hes observed among GLP-1 users
The challenges most people dont expect At Ultimate Performance, we regularly work with clients who are using GLP-1 drugs as part of their fitness journey